Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

15. Juni 2023 06:00 ET | Quelle: InvestmentPitch Media & MindBio Therapeutics

InvestmentPitch Media Video Discusses MindBio Therapeutics’ Clinical Trials of LSD-Microdosing Reveals Significant Positive Impact on Quality of Sleep

VANCOUVER, British Columbia, June 15, 2023 (GLOBE NEWSWIRE) -- MindBio Therapeutics (CSE:MBIO) (FSE:WF6), a Melbourne, Australia-based leader in microdosing psychedelic medicines, announced a...
31. Mai 2023 06:00 ET | Quelle: InvestmentPitch Media & MindBio Therapeutics

InvestmentPitch Media Video Discusses MindBio Therapeutics’ Receipt of Initial Shipment of 1,000,000 Microdoses of LSD for Phase 2 Clinical Trials for Depression

VANCOUVER, British Columbia, May 31, 2023 (GLOBE NEWSWIRE) -- MindBio Therapeutics (CSE:MBIO) (FSE:WF6), a Melbourne, Australia-based leader in microdosing psychedelic medicines, received its...
10. Mai 2023 11:01 ET | Quelle: InvestmentPitch Media & MindBio Therapeutics

MULTIMEDIA UPDATE - InvestmentPitch Media Video Discusses MindBio Therapeutics’ Take at Home LSD-Microdosing Clinical Trial Published in Peer Reviewed Paper in Biological Psychiatry

VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) -- MindBio Therapeutics (CSE:MBIO), through its scientific collaborators, has published its first Peer Reviewed Paper in Biological...
10. Mai 2023 06:00 ET | Quelle: InvestmentPitch Media & MindBio Therapeutics

InvestmentPitch Media Video Discusses MindBio Therapeutics’ Take at Home LSD-Microdosing Clinical Trial Published in Peer Reviewed Paper in Biological Psychiatry

VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) -- MindBio Therapeutics (CSE:MBIO), through its scientific collaborators, has published its first Peer Reviewed Paper in Biological...